Santa Monica, CA, United States of America

Ana Elena Minatti

This inventor holds 32 USPTO granted patents and 14 published patent applications, plus 3 CIPO patents and 15 EPO patents, primarily in Cancer Therapeutics. Top assignee: Amgen Inc.. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ana Elena Minatti. Retrieved from https://idiyas.com/inventor/ana-elena-minatti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 32 (Patent Applications = 14)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 10)

EPO Patents = 15 (Patent Applications = 21)

Average Co-Inventor Count = 11.3

ph-index = 7

Forward Citations = 223(Granted Patents)

Location History:

Woodland Hills, CA (US) (2014)
Thousand Oaks, CA (US) (2020 - 2022)
Santa Monica, CA (US) (2014 - 2024)
Los Angeles, CA (US) (2020 - 2024)

Company Filing History:

32 out of 2,074

Amgen Inc.

patents

Years Active: 2014-2025

Loading Chart...

Areas of Expertise:

KIF18A Inhibitors

KRAS G12C Inhibitors

Beta-Secretase Modulators

Heterocyclic Compounds

MCL-1 Protein Inhibitors

Piperazines

Amino-Dihydrothiazines

Cyclopropyl Compounds

Macrocyclic Compounds

Spiro-Amino Compounds

Perfluorinated Compounds

Isoindol-3-Amine Derivatives

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12509442 - KIF18A inhibitors (2025-12-30),

2. 12473289 - Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use (2025-11-18),

3. 12459932 - KIF18A inhibitors (2025-11-04),

4. 12448396 - Methods of using heterocyclic compounds as Delta-5 Desaturase inhibitors (2025-10-21),

5. 12440491 - KRAS G12C inhibitors and methods of using the same (2025-10-14),

6. 12083121 - Substituted piperazines as KRAS G12C inhibitors (2024-09-10),

7. 12054476 - KIF18A inhibitors (2024-08-06),

8. 11993597 - Inhibitors of KRAS G12C and methods of using the same (2024-05-28),

9. 11766436 - KRAS G12C inhibitors and methods of using the same (2023-09-26),

10. 11512097 - Heterocyclic compounds as Delta-5 desaturase inhibitors and methods of use (2022-11-29),

11. 11306087 - Inhibitors of KRAS G12C and methods of using the same (2022-04-19),

12. 11285156 - Substituted piperazines as KRAS G12C inhibitors (2022-03-29),

13. 11279712 - Macrocyclic compounds that inhibit MCL-1 protein (2022-03-22),

14. 11236069 - KIF18A inhibitors (2022-02-01),

15. 11224601 - Compounds that inhibits MCL-1 protein (2022-01-18),

Title: Pioneering Inventor Ana Elena Minatti: Pushing Boundaries and Inspiring Generations

Introduction:

Ana Elena Minatti, a trailblazing inventor based in Santa Monica, CA, is setting new standards in the world of innovation through her inventive spirit and collaborative efforts. With a remarkable dedication to pushing the boundaries of what is possible, Minatti continues to inspire future generations of inventors and innovators.

Latest Patents:

With an impressive portfolio of 25 patents, Ana Elena Minatti's latest groundbreaking inventions focus on the development of inhibitors of KRAS G12C and methods of using them. These innovative compounds hold significant promise in the treatment of various disorders, including pancreatic, colorectal, and lung cancers.

Career Highlights:

Currently affiliated with Amgen Inc., a renowned biotechnology company, Minatti stands at the forefront of cutting-edge research and development. Her expertise and contributions in the field have led to the creation of impactful solutions that benefit individuals worldwide.

Collaborations:

In her collaborative efforts, Ana Elena Minatti has worked closely with esteemed colleagues such as Jonathan Dante Low and Patricia Lopez. Together, they have synergized their expertise to drive innovation, cultivate creativity, and achieve remarkable milestones in the realm of science and technology.

Conclusion:

Ana Elena Minatti's remarkable journey as an inventor exemplifies the power of relentless passion, innovative thinking, and collaborative spirit in shaping a better future. Her pioneering work not only transforms industries but also serves as a beacon of inspiration for aspiring inventors and innovators around the globe.

Profile summary based on public USPTO records.